GlassScriptPhysician profile
Lillian Chloe Lloyd
NPI 1508496456
$547.38
in general payments reported to CMS, 2019-2025
14 companies · $145 in 2025
The $145 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $138 · 2022: $97.90 · 2023: $22.57 · 2024: $144 · 2025: $145.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $312.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $311.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertex Pharmaceuticals Incorporated | $118.23 | 2024-2025 | |
| Viiv Healthcare Company | $93.67 | 2024 | |
| Si-Bone, INC. | $62.81 | 2022-2023 | |
| Amgen INC. | $44.17 | 2021-2022 | |
| Bioventus LLC | $38.96 | 2022-2024 | Exogen Ultrasound Bone Healing System |
| Pacira Therapeutics, INC. | $30.97 | 2021 | |
| Trevena, INC. | $29.67 | 2021 | |
| Baudax Bio INC. | $23.61 | 2022 | |
| Boston Scientific Corporation | $22.69 | 2025 | Wavewriter Alpha Prime 16 |
| Kerecis Limited | $20.47 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Convatec INC. | $19.46 | 2021 | |
| Kci USA, INC. | $15.27 | 2021 | |
| Almatica Pharma LLC | $14.24 | 2024 | Teriparatide |
| Ethicon US, LLC | $13.16 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lillian Lloyd listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.